Venture-Backed Startups
101,692 companies with verified investor relationships.
BioPrex Medical develops permanent antimicrobial coatings for biomedical devices, using immobilized biocidal quaternary ammonium compounds (QACs) that kill bacteria on contact without leaching into body fluids. The non-leaching, contact-killing coatings are effective against both Gram-positive and Gram-negative bacteria and adaptable to a variety of surfaces.
1 investor
0 investors
0 investors
Bondwell Technologies develops a protein-based biomaterial platform that uses proteins to create materials for applications across energy, environmental, and medical fields. The company was founded by Texas A&M University scientists and is based in College Station, Texas.
1 investor
BioQ Pharma develops invenious, a patented "connect-and-go" delivery platform for infusible medicines that provides all-in-one, pre-filled, ready-to-use delivery systems tailored to specific dosing regimens. The technology targets drugs that are hard to prepare or administer and serves patients, healthcare providers, and payers.
0 investors
BioRaptor provides a bioprocess data management platform that stores and analyzes biological metrics to help biotechnology teams move from trial-and-error to optimized experimentation. The platform serves bioprocessing teams in R&D, scale-up, and production by making scientific data connected, contextualized, and actionable.
2 investors
Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.
2 investors
BioReact provides a data integration platform that unifies experimental data from bioreactors, laboratory instruments, and omics workflows into a standardized, AI-ready format for bioprocess development. The platform serves scientists in synthetic biology, cell therapy, biologics, and precision fermentation who need to consolidate fragmented scientific data for analytics and machine learning.
5 investors
0 investors
BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.
2 investors
BioRegenx is a health-technology holding company developing and acquiring patented regenerative biotherapeutics, anti-aging nutraceuticals, and AI-based health monitoring tools, including non-invasive microvascular imaging (GlycoCheck), a plant-based supplement (Endocalyx Pro), and contactless vital-sign analysis (DocSun). It sells through direct-to-institution, direct-to-practitioner, and direct-to-consumer models across the health, wellness, and longevity market.
0 investors
BioRender is a software tool that enables scientists to create and share professional scientific illustrations and figures. The platform serves researchers and scientists across life sciences disciplines globally.
4 investors
0 investors
0 investors
BioRestore is a healthcare clinic offering age-related and wellness treatments, including hormone/regenerative therapies and non-invasive pain treatments such as Bio Wave therapy, delivered by clinicians like nurse practitioners and physicians. It serves individual patients seeking evidence-based, patient-centric care, with a presence in New England.
1 investor
Bioretec develops fully biodegradable orthopedic implants for fracture healing and orthopedic surgery, including the RemeOs product line based on magnesium alloy and the Activa line of bioabsorbable implants. The company serves orthopedic surgeons and patients globally across approximately 40 countries.
1 investor
0 investors
BIOS develops neural digital therapy technology to deliver treatments for neurological conditions. The company combines neural engineering with AI and machine learning to improve healthcare outcomes and restore patient control over bodily function.
5 investors
Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
3 investors
BioScape Digital provides interactive patient-facing tools combining audio, text and visual media for healthcare settings, including educational content, provider tools, real-time patient satisfaction feedback, and games to occupy patients during wait times. The product is aimed at healthcare providers to support patient care and engagement.
0 investors
Bioscibex develops SW1NGO, a single-use system that automates the seed train in biologics manufacturing by scaling directly from 30 mL up to 30 L in one step, eliminating manual cell passaging and reducing contamination risks. It targets biopharma companies and CDMOs involved in upstream process development and manufacturing.
1 investor
0 investors
0 investors
0 investors